|
1
|
Arnold M, Sierra MS, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global patterns and trends in
colorectal cancer incidence and mortality. Gut. 66:683–691. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu L, Li X, Cai M, Chen J, Li X, Wu WK,
Kang W, Tong J, To KF, Guan XY, et al: Increased expression of
Solute carrier family 12 member 5 via gene amplification
contributes to tumour progression and metastasis and associates
with poor survival in colorectal cancer. Gut. 65:635–646. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ozawa T, Matsuyama T, Toiyama Y, Takahashi
N, Ishikawa T, Uetake H, Yamada Y, Kusunoki M, Calin G and Goel A:
CCAT1 and CCAT2 long noncoding RNAs, located within the 8q.24.21
‘gene desert’, serve as important prognostic biomarkers in
colorectal cancer. Ann Oncol. 28:1882–1888. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stein A, Atanackovic D and Bokemeyer C:
Current standards and new trends in the primary treatment of
colorectal cancer. Eur J Cancer. 47 (Suppl 3):S312–S314. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song W, Tiruthani K, Wang Y, Shen L, Hu M,
Dorosheva O, Qiu K, Kinghorn KA, Liu R and Huang L: Trapping of
lipopolysaccharide to promote immunotherapy against colorectal
cancer and attenuate liver metastasis. Adv Mater. 30:e18050072018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Downing A, Morris EJ, Corrigan N,
Sebag-Montefiore D, Finan PJ, Thomas JD, Chapman M, Hamilton R,
Campbell H, Cameron D, et al: High hospital research participation
and improved colorectal cancer survival outcomes: A
population-based study. Gut. 66:89–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Azvolinsky A: Colorectal cancer: To stack
or sequence therapy? J Natl Cancer Inst. 107:djv1382015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi X, Sun M, Liu H, Yao Y and Song Y:
Long non-coding RNAs: A new frontier in the study of human
diseases. Cancer Lett. 339:159–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Q, Huang J, Zhou N, Zhang Z, Zhang A,
Lu Z, Wu F and Mo YY: LncRNA loc285194 is a p53-regulated tumor
suppressor. Nucleic Acids Res. 41:4976–4987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yao N, Fu Y, Chen L, Liu Z, He J, Zhu Y,
Xia T and Wang S: Long non-coding RNA NONHSAT101069 promotes
epirubicin resistance, migration, and invasion of breast cancer
cells through NONHSAT101069/miR-129-5p/Twist1 axis. Oncogene.
38:7216–7233. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng J, Zhang H, Ma R, Liu H and Gao P:
Long non-coding RNA KRT19P3 suppresses proliferation and metastasis
through COPS7A-mediated NF-κB pathway in gastric cancer. Oncogene.
38:7073–7088. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan W, Sun Y, Liu L, Zhou B, Wang S and
Gu D: Circulating lncRNAs serve as diagnostic markers for
hepatocellular carcinoma. Cell Physiol Biochem. 44:125–132. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arriaga-Canon C, De La Rosa-Velázquez IA,
González-Barrios R, Montiel-Manríquez R, Oliva-Rico D,
Jiménez-Trejo F, Cortés-González C and Herrera LA: The use of long
non-coding RNAs as prognostic biomarkers and therapeutic targets in
prostate cancer. Oncotarget. 9:20872–20890. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang P, Ning S, Zhang Y, Li R, Ye J, Zhao
Z, Zhi H, Wang T, Guo Z and Li X: Identification of
lncRNA-associated competing triplets reveals global patterns and
prognostic markers for cancer. Nucleic Acids Res. 43:3478–3489.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y and Zhang J: Identification of
differential expression lncRNAs in gastric cancer using
transcriptome sequencing and bioinformatics analyses. Mol Med Rep.
17:8189–8195. 2018.PubMed/NCBI
|
|
16
|
Yang Y, Zhao Y, Zhang W and Bai Y: Whole
transcriptome sequencing identifies crucial genes associated with
colon cancer and elucidation of their possible mechanisms of
action. Onco Targets Ther. 12:2737–2747. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ren W, Zhang J, Li W, Li Z, Hu S, Suo J
and Ying X: A tumor-specific prognostic long non-coding RNA
signature in gastric cancer. Med Sci Monit. 22:3647–3657. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi X, Tan H, Le X, Xian H, Li X, Huang K,
Luo VY, Liu Y, Wu Z, Mo H, et al: An expression signature model to
predict lung adenocarcinoma-specific survival. Cancer Manag Res.
10:3717–3732. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bradford JR, Cox A, Bernard P and Camp NJ:
Consensus analysis of whole transcriptome profiles from two breast
cancer patient cohorts reveals long non-coding RNAs associated with
intrinsic subtype and the tumour microenvironment. PLoS One.
11:e01632382016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L and
Song X: Long noncoding RNA OCC-1 suppresses cell growth through
destabilizing HuR protein in colorectal cancer. Nucleic Acids Res.
46:5809–5821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang JZ, Chen M, Chen D, Gao XC, Zhu S,
Huang H, Hu M, Zhu H and Yan GR: A peptide encoded by a putative
lncRNA HOXB-AS3 suppresses colon cancer growth. Mol Cell.
68:171–184.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ma Y, Yang Y, Wang F, Moyer MP, Wei Q,
Zhang P, Yang Z, Liu W, Zhang H, Chen N, et al: Long non-coding RNA
CCAL regulates colorectal cancer progression by activating
Wnt/β-catenin signalling pathway via suppression of activator
protein 2α. Gut. 65:1494–1504. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiang JF, Yin QF, Chen T, Zhang Y, Zhang
XO, Wu Z, Zhang S, Wang HB, Ge J, Lu X, et al: Human colorectal
cancer-specific CCAT1-L lncRNA regulates long-range chromatin
interactions at the MYC locus. Cell Res. 24:513–531. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li C, Zheng H, Hou W, Bao H, Xiong J, Che
W, Gu Y, Sun H and Liang P: Long non-coding RNA linc00645 promotes
TGF-β-induced epithelial-mesenchymal transition by regulating
miR-205-3p-ZEB1 axis in glioma. Cell Death Dis. 10:7172019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng YJ, Zhao JY, Liang TS, Wang P, Wang
J, Yang DK and Liu ZS: Long noncoding RNA SMAD5-AS1 acts as a
microRNA-106a-5p sponge to promote epithelial mesenchymal
transition in nasopharyngeal carcinoma. FASEB J. 33:12915–12928.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mullighan CG, Collins-Underwood JR,
Phillips LA, Loudin MG, Liu W, Zhang J, Ma J, Coustan-Smith E,
Harvey RC, Willman CL, et al: Rearrangement of CRLF2 in
B-progenitor- and Down syndrome-associated acute lymphoblastic
leukemia. Nat Genet. 41:1243–1246. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Potter N, Jones L, Blair H, Strehl S,
Harrison CJ, Greaves M, Kearney L and Russell LJ: Single-cell
analysis identifies CRLF2 rearrangements as both early and late
events in Down syndrome and non-Down syndrome acute lymphoblastic
leukaemia. Leukemia. 33:893–904. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vesely C, Frech C, Eckert C, Cario G,
Mecklenbräuker A, Zur Stadt U, Nebral K, Kraler F, Fischer S,
Attarbaschi A, et al: Genomic and transcriptional landscape of
P2RY8-CRLF2-positive childhood acute lymphoblastic leukemia.
Leukemia. 31:1491–1501. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Morak M, Attarbaschi A, Fischer S,
Nassimbeni C, Grausenburger R, Bastelberger S, Krentz S, Cario G,
Kasper D, Schmitt K, et al: Small sizes and indolent evolutionary
dynamics challenge the potential role of P2RY8-CRLF2-harboring
clones as main relapse-driving force in childhood ALL. Blood.
120:5134–5142. 2012. View Article : Google Scholar : PubMed/NCBI
|
